Trial Profile
Intranasal Sedation With Dexmedetomidine and Ketamine in Pediatric Dentistry (NASO II): Randomized Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Ketamine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- Acronyms NASO II
- 11 Jun 2020 Status changed from active, no longer recruiting to completed.
- 02 Mar 2020 Planned End Date changed from 1 Dec 2021 to 31 Dec 2021.
- 02 Mar 2020 Status changed from recruiting to active, no longer recruiting.